Stay updated on Selpercatinib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Selpercatinib in Advanced Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedResults status changed from 'Results Submitted' (2025-10-20) to 'Results Posted' (2026-04-16), with added text describing the LIBRETTO-001 trial results and phase 2 cohorts. The update indicates public availability of the study results and related documentation.SummaryDifference6%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedMedullary thyroid carcinoma term added to the study conditions. Genetic and Rare Diseases Information Center resources added.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision: v3.5.0; Revision: v3.4.3 removed. The update appears to be an internal version bump with no visible changes to the study page content in the provided screenshots.SummaryDifference0.0%

- Check49 days agoChange DetectedPage revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check64 days agoChange DetectedResults status on the study page changed from 'No Results Posted' to 'Results Submitted'. This clarifies the availability of trial results for review by researchers, clinicians, and potential participants.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, indicating a minor site version update. This change does not affect the study details, enrollment, or other user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Selpercatinib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.